Follow the STARPHARMA HOLDINGS LIMITED share price and the full management transaction log of the company, a listed equity based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €345.9m. The latest transaction was reported on 24 August 2026 (Initial Substantial Holding). Among the most active insiders: 2. Details of voting power. The full history is openly available.
12
Insider Decl.
n/a
Thresholds
€189,166
5 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Buys €189,166n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,684 of 29,064 companies
40.1
score / 100
Value
28
Quality
52
FCF yld-2.0%
Earn yld-2.9%
EV/EBITDA·
ROE-14%
Gross mgn75%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
STARPHARMA HOLDINGS LIMITED es una empresa biofarmacéutica australiana centrada en el desarrollo de fármacos basados en su tecnología de polímeros patentada. Se enfoca en tratamientos para el cáncer y las infecciones virales.